Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,065,397
+$576,103 QoQ
Shares Held
39,708
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARRET ASSET MANAGEMENT, LLC holds $55,272,630 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
80,403 | $20,419,949 | |
| 2 | ABBV |
AbbVie Inc.
|
50,635 | $12,741,791 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,520 | $10,089,820 | |
| 4 | LLY |
ELI LILLY & Co
|
4,753 | $5,700,891 | |
| 5 | PFE |
Pfizer Inc
|
95,897 | $2,309,199 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
39,339 | $2,266,713 | |
| 7 | AMGN |
Amgen Inc
|
3,979 | $1,440,875 | |
| 8 | AZN |
Astrazeneca PLC
|
1,600 | $303,392 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,065,397 | 39,708 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,489,294 | 39,815 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,162,942 | 40,260 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,850,201 | 40,081 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,441,920 | 39,845 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $3,877,316 | 39,845 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,582,971 | 39,845 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $4,368,479 | 41,034 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,980,826 | 41,154 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $4,175,008 | 41,349 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $4,256,831 | 41,791 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,247,402 | 42,091 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,960,876 | 43,053 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,268,013 | 47,046 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $3,625,905 | 47,703 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,120,668 | 48,748 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $4,310,982 | 49,128 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $4,255,677 | 48,653 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $3,888,884 | 47,553 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $4,410,176 | 48,336 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $4,095,859 | 47,916 | Shares | Sole | 2021-07-14 | |
| 2020-12-31 | $4,522,819 | 47,896 | Shares | Sole | 2021-03-16 | |
| 2020-09-30 | $4,114,599 | 47,316 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,128,212 | 47,266 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,907,800 | 47,396 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||